The deal could signal that Elevance wants to build out its commercial products to hedge against volatility in Medicaid and ...

Omega-3 and vitamin D supplements, when combined with regular exercise, may help slow biological aging by several months over ...

Verily, Alphabet Inc.'s health technology subsidiary, announced Thursday it will sell its stop-loss insurance business, ...

Alphabet's Verily is selling its subsidiary, Granular Insurance Company, to Elevance Health. Verily launched Granular in 2020 ...

Elevance Health Inc. closed 31.17% below its 52-week high of $567.26, which the company reached on September 3rd.

Joanna Gajuk, an analyst from Bank of America Securities, reiterated the Hold rating on Elevance Health (ELV – Research Report). The associated price target is $465.00. Joanna Gajuk’s rating ...

Elevance Health Inc (NYSE:ELV) reported fourth-quarter adjusted diluted earnings per share of $3.84, consistent with prior expectations. The company achieved strong member retention in its ...

Elevance Health Inc (NYSE:ELV) reported fourth-quarter adjusted diluted earnings per share of $3.84, consistent with prior expectations. The company achieved strong member retention in its Medicare ...

Gail Boudreaux; President, Chief Executive Officer, Director; Elevance Health Inc Mark Kaye; Chief Financial Officer, Executive Vice President; Elevance Health Inc Felicia Norwood; Executive Vice ...

Elevance Health delivered earnings and 2025 guidance that broadly met analysts’ expectations, likely providing some relief to investors after a challenging quarter. The fourth-quarter results ...

Elevance Health Inc. shares rose as its medical costs were lower than expected in the fourth quarter, relieving investor anxiety and helping the insurer meet profit expectations. Quarterly profit was ...